Skip to main content
2025 ACVIM Forum Main banner
Icon Legend
This session is not on your agenda.
This session is on your agenda. Click again to remove it.
Presentation Icons
ACVIM Resident Research Award Eligible
ACVIM Resident Research Award Eligible
Additional Fees May Be Required
Additional Fees May Be Required
By Invite Only
By Invite Only
Capturing for On Demand
Capturing for On Demand
Cardiology Research Abstract Award Eligible
Cardiology Research Abstract Award Eligible
ERC Approved Lecture for ACVIM Residency
ERC Approved Lecture for ACVIM Residency
Poster
Poster
Livestream
Livestream
One Health
One Health
Pre-Registration Required
Pre-Registration Required
Research Abstract
Research Abstract
Specialty Symposium
Specialty Symposium
ACVIM Resident Research Award Winner
ACVIM Resident Research Award Winner
Cardiology Research Abstract Award Winner
Cardiology Research Abstract Award Winner
Back
ViewAttendees 3

Small Animal Internal Medicine

Panel: Controversies in Diabetes Mellitus in Dogs and Cats

Friday, June 20, 2025
1:30 PM – 3:45 PM ET
Pending CE: 2.0 Medical
Capturing for On Demand
Disclosure(s):
Sean E. Hulsebosch, DVM, DACVIM (SAIM): No financial relationships to disclose
Linda M. Fleeman, BVSc, PhD, MANZCVS: No relevant disclosure to display
Presentation Description / Summary: This roundtable panel discussion will focus on controversies, latest developments, and current research in diabetes mellitus in dogs and cats. We will explore questions such as “Which is the best insulin?”, “Should hypoglycemia be a main consideration in management of the routine diabetic?”, “Is urine glucose a valid method of monitoring?”, “Is separating insulin administration from feeding a safe strategy in general, or just in patients treated with a basal insulin?”, "Are SGLT2 inhibitors and GLP-1 agonists alternatives to insulin or should they only be used in tandem with insulin?”, and more.

Learner Outcomes: 1. Be familiar with the latest insulin formulations and novel applications of these formulations to the therapy of dogs and cats. 2. Knowledge of and proper use of SGLT-2 inhibitors and GLP-1 agonists. 3. Be familiar with newest classification schemes of diabetes mellitus types in dogs and cats and how this affects management.

Learning Objectives:

  • ...become familiar with the latest insulin formulations and novel applications of these formulations to the therapy of dogs and cats.
  • ...gain knowledge of and feel comfortable using SGLT-2 inhibitors and GLP-1 agonists.
  • ... be familiar with the newest classification schemes of diabetes mellitus types in dogs and cats and how this affects management.